METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis
Authors
Keywords
-
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-10-26
DOI
10.1016/j.bbrc.2022.10.065
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner
- (2022) Yun-zhang Dai et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- The emerging roles of RNA m6A methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance
- (2021) Qing Lan et al. CANCER RESEARCH
- Physio-pathological effects of m6A modification and its potential contribution to melanoma
- (2021) Y. Liao et al. Clinical & Translational Oncology
- METTL16 promotes cell proliferation by up‐regulating cyclin D1 expression in gastric cancer
- (2021) Xiao‐Kun Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A comprehensive review of m6A/m6Am RNA methyltransferase structures
- (2021) Stephanie Oerum et al. NUCLEIC ACIDS RESEARCH
- Interactions between m6A modification and miRNAs in malignant tumors
- (2021) Xiao Han et al. Cell Death & Disease
- Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets
- (2021) Da-Hong Chen et al. Frontiers in Cell and Developmental Biology
- Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
- (2020) Yanwei Su et al. CANCER LETTERS
- The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis
- (2020) Mengnuo Chen et al. Molecular Cancer
- The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression
- (2020) Yuqing Wu et al. Molecular Cancer
- Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death
- (2020) Anna Martina Battaglia et al. Cells
- Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
- (2020) Pranavi Koppula et al. Protein & Cell
- Expression and Prognostic Characteristics of m6 A RNA Methylation Regulators in Breast Cancer
- (2020) Bo Zhang et al. Frontiers in Genetics
- Ferroptosis, a new form of cell death: opportunities and challenges in cancer
- (2019) Yanhua Mou et al. Journal of Hematology & Oncology
- The role of m6A RNA methylation in cancer
- (2019) Ting Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting Ferroptosis to Iron Out Cancer
- (2019) Behrouz Hassannia et al. CANCER CELL
- Therapeutic landscape of metaplastic breast cancer
- (2019) N. Tray et al. CANCER TREATMENT REVIEWS
- Recent Progress in Ferroptosis Inducers for Cancer Therapy
- (2019) Chen Liang et al. ADVANCED MATERIALS
- The interplay between m6A RNA methylation and noncoding RNA in cancer
- (2019) Shuai Ma et al. Journal of Hematology & Oncology
- Structural insights into the RNA methyltransferase domain of METTL16
- (2018) Agnieszka Ruszkowska et al. Scientific Reports
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started